Stantec (STN) Competitors

IQVIA (NYSE:IQV) and Stantec (NYSE:STN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, community ranking, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

Does the MarketBeat Community favor IQV or STN?

IQVIA received 270 more outperform votes than Stantec when rated by MarketBeat users. Likewise, 68.32% of users gave IQVIA an outperform vote while only 59.97% of users gave Stantec an outperform vote.

Company	Underperform	Outperform
IQVIA	Outperform Votes 673 68.32%	Underperform Votes 312 31.68%
Stantec	Outperform Votes 403 59.97%	Underperform Votes 269 40.03%

Does the media prefer IQV or STN?

In the previous week, IQVIA had 13 more articles in the media than Stantec. MarketBeat recorded 18 mentions for IQVIA and 5 mentions for Stantec. Stantec's average media sentiment score of 1.13 beat IQVIA's score of 0.70 indicating that Stantec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IQVIA	4 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
Stantec	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, IQV or STN?

IQVIA has a beta of 1.49, meaning that its share price is 49% more volatile than the S&P 500. Comparatively, Stantec has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.

Do analysts prefer IQV or STN?

IQVIA presently has a consensus price target of $255.82, indicating a potential upside of 29.68%. Given IQVIA's stronger consensus rating and higher possible upside, research analysts clearly believe IQVIA is more favorable than Stantec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IQVIA	0 Sell rating(s)	3 Hold rating(s)	17 Buy rating(s)	1 Strong Buy rating(s)	2.90
Stantec	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Is IQV or STN more profitable?

IQVIA has a net margin of 9.17% compared to Stantec's net margin of 4.78%. IQVIA's return on equity of 28.17% beat Stantec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IQVIA	9.17%	28.17%	6.89%
Stantec	4.78%	16.57%	6.99%

Do institutionals & insiders have more ownership in IQV or STN?

89.6% of IQVIA shares are held by institutional investors. Comparatively, 63.9% of Stantec shares are held by institutional investors. 1.6% of IQVIA shares are held by insiders. Comparatively, 0.5% of Stantec shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has better earnings and valuation, IQV or STN?

IQVIA has higher revenue and earnings than Stantec. IQVIA is trading at a lower price-to-earnings ratio than Stantec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IQVIA	$15.32B	2.34	$1.36B	$7.62	25.89
Stantec	$7.15B	1.27	$245.35M	$2.20	36.14

Summary

IQVIA beats Stantec on 16 of the 19 factors compared between the two stocks.